...ecember 5, 2007, 2007) In the wake of a study tha...y by Cross River gorillas to ward off threats by h... today new field surveys to better protect this mo...arlier this year in the Journal of Primatology, fo...and clumps of grass when threatened by people. Go...
...5 December 2007 - If you needed to see a specimen ..., would you know where to look? Finding a natural...icular time or place right now is mostly a matter ...n Facility (GBIF), Biodiversity Information Standa...are paving the way for more effective internationa...
... After an injury, the body grows new blood vessels...growth causes problems, as when new blood vessels ... blindness if not treated. , A protein called CIB...orth Carolina at Chapel Hill School of Medicine ap...d vessel growth, offering a target for drug treatm...
Other Biology News:GBIF making the search for biodiversity research resources easier 2Protein controls blood vessel formation, offers new drug target 2(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company,specializing in the development, manufacturing, a
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3... International,Corporation (Nasdaq: PRXL ) announ...hief Executive Officer, will be presenting at the ...e Four Seasons Hotel in Boston,on Friday, Septembe...entation can be accessed through the "Investor Rel... http://www.PAREXEL.com and a replay of the,prese...
...Veteran Richard Franco and Entrepreneur Anthony ...ctors, IRVINE, Calif., Sept. 5 NeoMatrix, develo...omatic, noninvasive test designed to,identify brea...as closed a,Series C round of equity financing. Th... of the HALO System, which is designed to test asy...
...a Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced ...the Bear Stearns 20th Annual Healthcare Conference...12:30 p.m. Pacific Time) at the Grand,Hyatt Hotel ... Chief,Executive Officer, is scheduled to provide ...al development and discovery programs. A live aud...
Other Biology Technology:PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 2NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 2NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 3NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test 4Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference 3Anti-Human Amyloid beta [1-16] Monoclonal Antibody, Unconjugated, Clone 6E10 from Cell Sciences
Anti-HES-1 Antibody, Unconjugated from CHEMICON
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: